⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9787610 | 0.89 | ADRA2A (0.34) | — | |
| SCHEMBL14030019 | 0.76 | SLC6A4 (0.32) | — | |
| SCHEMBL278239 | 0.74 | — | — | |
| SCHEMBL14004836 | 0.74 | — | — | |
| SCHEMBL9869077 | 0.72 | USP2 (0.37) | — | |
| SCHEMBL9869071 | 0.72 | — | — | |
| SCHEMBL2519760 | 0.72 | MAPT (0.35) | — | |
| SCHEMBL4107607 | 0.71 | NAMPT (0.36) | — | |
| SCHEMBL21789657 | 0.71 | — | — | |
| SCHEMBL5468024 | 0.71 | NAMPT (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119137109-A | Lipids for nucleic acid delivery | 生命技术公司 | 2024-12-13 | — | — | CN | claimed |
| EP-1453869-A2 | MICROSTRUCTURE MODIFIER FOR ANIONIC POLYMERIZATION | Hellermann, Walter (DE) | 2004-09-08 | — | — | EP | claimed |
| WO-2003044065-A2 | MICROSTRUCTURE MODIFIER FOR ANIONIC POLYMERIZATION | HELLERMANN WALTER (DE) | 2003-05-30 | — | — | WO | claimed |
| CN-119913180-A | MRNA vaccine against varicella zoster virus | 南京奥罗生物科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119913179-A | MRNA vaccine against varicella zoster virus | 南京奥罗生物科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119913181-A | MRNA vaccine against varicella zoster virus | 南京奥罗生物科技有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-119876190-A | Combination vaccine against coronavirus and influenza virus | 南京奥罗生物科技有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119451666-A | Lipid nanoparticles for gene editing systems | 奥泽生物疗法公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-113423418-B | Treatment of cilia disease | 埃泽瑞斯公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-119110732-A | Gene editing for improving joint function | 奥泽生物疗法公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-119053696-A | Transmembrane receptor gene editing | 奥泽生物疗法公司 | 2024-11-29 | — | — | CN | disclosed |
| US-20070270407-A1 | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones | THE PROCTER & GAMBLE COMPANY | 2007-11-22 | — | — | US | disclosed |
| US-7250429-B2 | Aminomethyl-substituted thiazolobenzimidazole compounds | ASTELLAS PHARMA INC. (JP) | 2007-07-31 | — | — | US | disclosed |
| US-7250429-B2 | Aminomethyl-substituted thiazolobenzimidazole compounds | ASTELLAS PHARMA INC. (JP) | 2007-07-31 | — | — | US | disclosed |
| US-7247648-B2 | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones | THE PROCTER & GAMBLE COMPANY (US) | 2007-07-24 | — | — | US | disclosed |
| WO-2004089925-A1 | PI-3 KINASE INHIBITOR PRODRUGS | SEMAFORE PHARMACEUTICALS, INC. (US) | 2004-10-21 | — | — | WO | disclosed |
| EP-1453869-A2 | MICROSTRUCTURE MODIFIER FOR ANIONIC POLYMERIZATION | Hellermann, Walter (DE) | 2004-09-08 | — | — | EP | disclosed |
| WO-2004069826-A1 | MALONAMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-08-19 | — | — | WO | disclosed |
| US-20040097560-A1 | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones | THE PROCTER & GAMBLE COMPANY | 2004-05-20 | — | — | US | disclosed |
| WO-2003044065-A2 | MICROSTRUCTURE MODIFIER FOR ANIONIC POLYMERIZATION | HELLERMANN WALTER (DE) | 2003-05-30 | — | — | WO | disclosed |